Sansure Biotech Inc. (SHA:688289)
14.76
-0.25 (-1.67%)
Nov 17, 2026, 3:00 PM CST
Sansure Biotech Market Cap
Sansure Biotech has a market cap or net worth of 8.39 billion as of November 17, 2026. It is the 8,505th most valuable company in the world and the 1,739th biggest in China. Its market cap has decreased by 33.35% in one year.
Market Cap
8.39B
Enterprise Value
6.36B
Revenue
1.65B
Global Rank
Country Rank
#1,739 China
PE Ratio
77.17
ChartMarket Cap Chart
Since August 28, 2020, Sansure Biotech's market cap has decreased from 46.42B to 8.39B, a decrease of -81.94%. That is a compound annual growth rate of -24.04%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 17, 2026 | 8.39B | -22.77% |
| Dec 31, 2025 | 10.86B | -16.48% |
| Dec 31, 2024 | 13.00B | 16.22% |
| Dec 29, 2023 | 11.19B | -12.24% |
| Dec 30, 2022 | 12.75B | -45.99% |
| Dec 31, 2021 | 23.60B | -48.22% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Aug 28, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Jiangsu Hualan New Pharmaceutical Material | 10.33B |
| Tofflon Science and Technology Group | 9.71B |
| Autek China | 9.15B |
| Eyebright Medical Technology (Beijing) | 8.02B |
| Mingyue Optical Lens | 7.55B |
| Tinavi Medical Technologies | 6.81B |
| Caina Technology | 6.59B |
| Zhonghong Pulin Medical Products | 6.33B |